RT-SHIV MODEL FOR RESISTANCE TO AIDS THERAPY
RT-SHIV MODEL FOR RESISTANCE TO AIDS THERAPY
批准号:
6555277
负责人:
THOMAS W NORTH
金额:
$1.35万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-01 至 2003-07-31
关键词:
AIDS therapy HIV infections Macaca antiAIDS agent biological models combination chemotherapy disease /disorder model drug resistance human immunodeficiency virus 1 model design /development protease inhibitor recombinant virus reverse transcriptase inhibitors simian AIDSs simian immunodeficiency virus
中文摘要
描述:(改编自申请者摘要):高度活跃
抗逆转录病毒疗法(HAART)是#年艾滋病治疗的重大进展。
人类。HAART可长期抑制无法检测到的HIV-1病毒载量
在许多患者中的水平。然而,HIV-1仍处于潜伏或持续状态
在这些患者中形成,并可在停止药物治疗后重新出现。
HAART或其他治疗方法的另一个主要障碍是出现
艾滋病毒-1的耐药和多药耐药变种。的一个主要目标
该项目是在动物模型上建立类似HAART的治疗方法。我们的目标是
不是为了提供药物测试系统,而是为了进一步发展动物
可用于艾滋病治疗研究的模型系统
在感染了HIV-1的人身上很难或不可能做到的事情。在……里面
特别是,我们希望研究低水平病毒复制和
HAART期间的延迟/持久性。出于这个原因,我们将使用嵌合体
含有HIV-1逆转录酶的猿猴免疫缺陷病毒
(RT-SHIV),这将使体外和体内研究组合成为可能
含有核苷类似物和非核苷反向抑制剂
转录酶(NNRTI)。我们还将把这个模型用于药物研究。
含有蛋白水解酶抑制剂的组合。利用长期目标
在长时间内探测病毒复制和/或持续位置的模型
HAART,并评估其他干预方法,试图根除
来自水库的病毒。
英文摘要
DESCRIPTION: (Adapted from the Applicant's Abstract): Highly active
antiretroviral therapy (HAART) has been a major advance in treatment of AIDS in
humans. HAART provides long term suppression of HIV-1 loads to undetectable
levels in many patients. Nevertheless, HIV-1 remains in a latent or persistent
form in these patients and can reemerge when drug therapy is discontinued.
Another major barrier to HAART or other therapeutic approaches is the emergence
of drug-resistant and multi-drug resistant variants of HIV-1. A major goal of
this project is to establish HAART-like therapy in an animal model. Our goal is
not to provide a drug testing system but rather to further develop the animal
model system to the point where it can be useful for studies of AIDS therapy
that are difficult or impossible to do in humans infected by HIV-1. In
particular, we wish to study sites of low-level virus replication and
latency/persistence during HAART. For this reason, we will use a chimera of
simian immunodeficiency virus (SIV) containing the HIV-1 reverse transcriptase
(RT-SHIV), which will enable in vitro and in vivo studies of combinations
containing nucleoside analogs and non-nucleoside inhibitors of reverse
transcriptase (NNRTI). We will also use this model for studies of drug
combinations that include protease inhibitors. Long-term goals are (to) utilize
the model to probe sites of virus replication and/or persistence in prolonged
HAART, and to evaluate other intervention approaches in attempts to eradicate
virus from reservoirs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TARGETED TOXIN THERAPY IN MACAQUE MODEL FOR AIDS
-
批准号:8357361
-
项目类别:
-
资助金额:$9.57万
-
财政年份:2011
-
负责人:THOMAS W NORTH
-
依托单位:
PRIMATE MODEL TOWARDS HIV ERADICATION STRATEGIES
-
批准号:8357336
-
项目类别:
-
资助金额:$14.36万
-
财政年份:2011
-
负责人:THOMAS W NORTH
-
依托单位:
PRIMATE MODEL TOWARDS HIV ERADICATION STRATEGIES
-
批准号:8172619
-
项目类别:
-
资助金额:$11.41万
-
财政年份:2010
-
负责人:THOMAS W NORTH
-
依托单位:
Primate Model Towards HIV Eradication Strategies
-
批准号:7756368
-
项目类别:
-
资助金额:$74.79万
-
财政年份:2009
-
负责人:THOMAS W NORTH
-
依托单位:
Core - Animal Model
-
批准号:7899492
-
项目类别:
-
资助金额:$70.36万
-
财政年份:2009
-
负责人:THOMAS W NORTH
-
依托单位:
Primate Model Towards HIV Eradication Strategies
-
批准号:8292211
-
项目类别:
-
资助金额:$70.59万
-
财政年份:2009
-
负责人:THOMAS W NORTH
-
依托单位:
Primate Model Towards HIV Eradication Strategies
-
批准号:8053394
-
项目类别:
-
资助金额:$70.59万
-
财政年份:2009
-
负责人:THOMAS W NORTH
-
依托单位:
A MONKEY MODEL FOR ANTI-CYTOMEGALOVIRUS THERAPY
-
批准号:7715616
-
项目类别:
-
资助金额:$8.45万
-
财政年份:2008
-
负责人:THOMAS W NORTH
-
依托单位:
A MONKEY MODEL FOR ANTI-CYTOMEGALOVIRUS THERAPY
-
批准号:7562210
-
项目类别:
-
资助金额:$5.74万
-
财政年份:2007
-
负责人:THOMAS W NORTH
-
依托单位:
A MONKEY MODEL FOR ANTI-CYTOMEGALOVIRUS THERAPY
-
批准号:7349723
-
项目类别:
-
资助金额:$4.97万
-
财政年份:2006
-
负责人:THOMAS W NORTH
-
依托单位:
ANIMAL MODEL CORE
-
批准号:7349722
-
项目类别:
-
资助金额:$7.83万
-
财政年份:2006
-
负责人:THOMAS W NORTH
-
依托单位:
A Monkey Model for Anti-Cytomegalovirus Therapy
-
批准号:6925260
-
项目类别:
-
资助金额:$18.84万
-
财政年份:2005
-
负责人:THOMAS W NORTH
-
依托单位:
A Monkey Model for Anti-Cytomegalovirus Therapy
-
批准号:7027021
-
项目类别:
-
资助金额:$22.19万
-
财政年份:2005
-
负责人:THOMAS W NORTH
-
依托单位:
Combinatorial Chemistry for HIV Entry Inhibitors
-
批准号:7224942
-
项目类别:
-
资助金额:$34.99万
-
财政年份:2004
-
负责人:THOMAS W NORTH
-
依托单位:
Combinatorial Chemistry for HIV Entry Inhibitors
-
批准号:6888551
-
项目类别:
-
资助金额:$36.9万
-
财政年份:2004
-
负责人:THOMAS W NORTH
-
依托单位:
Combinatorial Chemistry for HIV Entry Inhibitors
-
批准号:6745375
-
项目类别:
-
资助金额:$36.9万
-
财政年份:2004
-
负责人:THOMAS W NORTH
-
依托单位:
Combinatorial Chemistry for HIV Entry Inhibitors
-
批准号:7049364
-
项目类别:
-
资助金额:$36.03万
-
财政年份:2004
-
负责人:THOMAS W NORTH
-
依托单位:
Animal Model Core
-
批准号:6844103
-
项目类别:
-
资助金额:$28.85万
-
财政年份:2004
-
负责人:THOMAS W NORTH
-
依托单位:
SIV MODEL FOR MULTI DRUG RESISTANCE TO AIDS THERAPY
-
批准号:6940442
-
项目类别:
-
资助金额:$4.26万
-
财政年份:2003
-
负责人:THOMAS W NORTH
-
依托单位:
RT-SHIV MODEL FOR RESISTANCE TO AIDS THERAPY
-
批准号:6940441
-
项目类别:
-
资助金额:$7.15万
-
财政年份:2003
-
负责人:THOMAS W NORTH
-
依托单位:
海外基金